168 related articles for article (PubMed ID: 33921688)
1. Infiltration of Immune Competent Cells into Primary Tumors and Their Surrounding Connective Tissues in Xenograft and Syngeneic Mouse Models.
Metzen M; Bruns M; Deppert W; Schumacher U
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921688
[TBL] [Abstract][Full Text] [Related]
2. Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer.
Pan Y; Lu F; Fei Q; Yu X; Xiong P; Yu X; Dang Y; Hou Z; Lin W; Lin X; Zhang Z; Pan M; Huang H
J Hematol Oncol; 2019 Nov; 12(1):124. PubMed ID: 31771616
[TBL] [Abstract][Full Text] [Related]
3. Early-appearing tumor-infiltrating natural killer cells play an important role in the nitric oxide production of tumor-associated macrophages through their interferon production.
Abe K; Harada M; Tamada K; Ito O; Li T; Nomoto K
Cancer Immunol Immunother; 1998 Jan; 45(5):225-33. PubMed ID: 9439645
[TBL] [Abstract][Full Text] [Related]
4.
Shevtsov M; Pitkin E; Ischenko A; Stangl S; Khachatryan W; Galibin O; Edmond S; Lobinger D; Multhoff G
Front Immunol; 2019; 10():454. PubMed ID: 30967859
[TBL] [Abstract][Full Text] [Related]
5. Immune Cell Composition in Human Non-small Cell Lung Cancer.
Stankovic B; Bjørhovde HAK; Skarshaug R; Aamodt H; Frafjord A; Müller E; Hammarström C; Beraki K; Bækkevold ES; Woldbæk PR; Helland Å; Brustugun OT; Øynebråten I; Corthay A
Front Immunol; 2018; 9():3101. PubMed ID: 30774636
[TBL] [Abstract][Full Text] [Related]
6. Immune responsiveness in a mouse model of combined adoptive immunotherapy with NK and dendritic cells.
Cui F; Ji J; Lv H; Qu D; Yu C; Yang Y; Xu Y
J Cancer Res Ther; 2013 Nov; 9 Suppl():S162-8. PubMed ID: 24516054
[TBL] [Abstract][Full Text] [Related]
7. An Antibody Designed to Improve Adoptive NK-Cell Therapy Inhibits Pancreatic Cancer Progression in a Murine Model.
Lee J; Kang TH; Yoo W; Choi H; Jo S; Kong K; Lee SR; Kim SU; Kim JS; Cho D; Kim J; Kim JY; Kwon ES; Kim S
Cancer Immunol Res; 2019 Feb; 7(2):219-229. PubMed ID: 30514792
[TBL] [Abstract][Full Text] [Related]
8. Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents.
Kuhn S; Hyde EJ; Yang J; Rich FJ; Harper JL; Kirman JR; Ronchese F
J Immunol; 2013 Aug; 191(4):1984-92. PubMed ID: 23858033
[TBL] [Abstract][Full Text] [Related]
9. Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.
Ohshio Y; Teramoto K; Hanaoka J; Tezuka N; Itoh Y; Asai T; Daigo Y; Ogasawara K
Cancer Sci; 2015 Feb; 106(2):134-42. PubMed ID: 25483888
[TBL] [Abstract][Full Text] [Related]
10. Animal models for studying tumor microenvironment (TME) and resistance to lymphocytic infiltration.
Yamaguchi R; Perkins G
Cancer Biol Ther; 2018; 19(9):745-754. PubMed ID: 29723108
[TBL] [Abstract][Full Text] [Related]
11. Response to Programmed Cell Death-1 Blockade in a Murine Melanoma Syngeneic Model Requires Costimulation, CD4, and CD8 T Cells.
Homet Moreno B; Zaretsky JM; Garcia-Diaz A; Tsoi J; Parisi G; Robert L; Meeth K; Ndoye A; Bosenberg M; Weeraratna AT; Graeber TG; Comin-Anduix B; Hu-Lieskovan S; Ribas A
Cancer Immunol Res; 2016 Oct; 4(10):845-857. PubMed ID: 27589875
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory cell infiltration of tumors: Jekyll or Hyde.
Talmadge JE; Donkor M; Scholar E
Cancer Metastasis Rev; 2007 Dec; 26(3-4):373-400. PubMed ID: 17717638
[TBL] [Abstract][Full Text] [Related]
13. Dendritic cell-induced activation of adaptive and innate antitumor immunity.
van den Broeke LT; Daschbach E; Thomas EK; Andringa G; Berzofsky JA
J Immunol; 2003 Dec; 171(11):5842-52. PubMed ID: 14634094
[TBL] [Abstract][Full Text] [Related]
14. The bispecific immunoligand ULBP2-aCEA redirects natural killer cells to tumor cells and reveals potent anti-tumor activity against colon carcinoma.
Rothe A; Jachimowicz RD; Borchmann S; Madlener M; Keßler J; Reiners KS; Sauer M; Hansen HP; Ullrich RT; Chatterjee S; Borchmann P; Yazaki P; Koslowsky TC; Engert A; Heukamp LC; Hallek M; von Strandmann EP
Int J Cancer; 2014 Jun; 134(12):2829-40. PubMed ID: 24242212
[TBL] [Abstract][Full Text] [Related]
15. Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-γ, CXCL9 and CXCL10.
Bergamaschi C; Pandit H; Nagy BA; Stellas D; Jensen SM; Bear J; Cam M; Valentin A; Fox BA; Felber BK; Pavlakis GN
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32461349
[TBL] [Abstract][Full Text] [Related]
16. Immune infiltration and PD-L1 expression in the tumor microenvironment are prognostic in osteosarcoma.
Koirala P; Roth ME; Gill J; Piperdi S; Chinai JM; Geller DS; Hoang BH; Park A; Fremed MA; Zang X; Gorlick R
Sci Rep; 2016 Jul; 6():30093. PubMed ID: 27456063
[TBL] [Abstract][Full Text] [Related]
17. Destructive impact of T-lymphocytes, NK and Mast cells on basal cell layers: implications for tumor invasion.
Yuan H; Hsiao YH; Zhang Y; Wang J; Yin C; Shen R; Su Y
BMC Cancer; 2013 May; 13():258. PubMed ID: 23705594
[TBL] [Abstract][Full Text] [Related]
18. Benefits of a continuous therapy for cancer patients with a novel adoptive cell therapy by cascade priming (CAPRI).
Wank R; Song X; Gu S; Laumbacher B
Immunotherapy; 2014; 6(3):269-82. PubMed ID: 24762072
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical Analysis of Scarring Trachoma Indicates Infiltration by Natural Killer and Undefined CD45 Negative Cells.
Hu VH; Luthert PJ; Derrick T; Pullin J; Weiss HA; Massae P; Mtuy T; Makupa W; Essex D; Mabey DC; Bailey RL; Holland MJ; Burton MJ
PLoS Negl Trop Dis; 2016 May; 10(5):e0004734. PubMed ID: 27219121
[TBL] [Abstract][Full Text] [Related]
20. Anti-PD-1 therapy redirects macrophages from an M2 to an M1 phenotype inducing regression of OS lung metastases.
Dhupkar P; Gordon N; Stewart J; Kleinerman ES
Cancer Med; 2018 Jun; 7(6):2654-2664. PubMed ID: 29733528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
